Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (INTERCEPTioN for Suspected Lung Cancer)for Suspected Lung Cancer)

NCT06482073 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06482073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06482073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (INTERCEPTioN for Suspected Lung Cancer)for Suspected Lung Cancer)
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
June 24, 2024
Completion date
July 1, 2027
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung carcinoma, metastatic malignant neoplasm in the lung